相关实验视频
Updated: Jan 15, 2026

10:53
Author Spotlight: Mitochondrial Remodeling in Skeletal Muscle
Published on: December 1, 2023
4.3K
Sirt3-CD38轴通过调节线粒体过载,诱导心脏缩的线粒体功能障碍
1Department of Cardiology, The Second Hospital of Jilin University, Changchun, 130041, China.
European journal of medical research
|October 15, 2025
概括
心脏缩中的线粒体功能障碍与过载有关. 赛尔图因-3 (Sirt3) 缺乏通过CD38加剧,影响心脏健康.
科学领域:
- 心血管生物学 心血管生物学
- 线粒体医学 线粒体医学
- 分子心脏病学分子心脏病学
背景情况:
- 线粒体功能障碍和过载是心脏缩的关键.
- 在这个过程中,Sirtuin-3 (Sirt3) 的确切作用及其与CD38介导的NAD枯竭的联系尚未完全理解.
研究的目的:
- 研究通过CD38导致Sirt3缺乏导致心脏缩中的线粒体失调的机制.
- 探索针对Sirt3-CD38轴的治疗潜力.
主要方法:
- 用Sirt3缺乏的小鼠作为心脏缩模型.
- 采用了血氨酸和氨酸染色,传输电子显微镜和多组学方法 (基因和代谢物分析).
- 在Sirt3敲击的H9C2细胞上进行了体外研究,评估反应性氧物种 (ROS),线粒体和膜潜力 (MMP),以及西斑和qPCR.
主要成果:
- 在小鼠中,Sirt3 缺乏导致心肌纤维变厚,并改变了线粒体形态,与抑制氧化酸化 (OXPHOS) 复杂子单元翻译有关.
- 多omics确定CD38作为一个重要的NAD消费者,将其代谢物连接到cAMP信号传输.
- 在体外,Sirt3敲除通过促进MCU表达增加了ROS,降低了MMP,并增加了线粒体过载;CD38抑制剂逆转了这些效应.
结论:
- Sirt3-CD38轴通过加剧线粒体过载,驱动高缩心脏中的线粒体功能障碍.
- 向CD38提供了一个潜在的治疗策略,通过恢复线粒体功能来治疗与年龄相关的心脏缩.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Mitochondrial Membranes
16.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Heart Failure II: Pathophysiology
722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722
Mitochondria
19.6K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.6K

